Meeting

In-Person DC Roundtable: National Security and the U.S. Pharma and Biotech Industries

Tuesday, June 25, 2024
Thomas Peter/REUTERS
Speakers
Monique K. Mansoura

Executive Director, Global Health Security and Biotechnology, The MITRE Corporation

Victor Suarez

Colonel (Ret), U.S. Army, Senior Fellow (Visiting), The Council on Strategic Risks; Founder, BluZoneBio

Presider
David P. Fidler

Senior Fellow for Global Health and Cybersecurity, Council on Foreign Relations

from Roundtable Series on U.S. Foreign Policy and Global Health

The COVID-19 pandemic and chronic U.S. drug shortages highlight the health security and strategic importance of U.S. pharmaceutical and biotechnology capabilities during and between pathogenic crises. Geopolitical competition and interest in industrial policy for biotechnology further underscore the national security role of domestic biopharmaceutical infrastructure. Policymakers confront competing health, economic, and strategic priorities in maximizing innovation in technology, business models, and health-care systems in facilitating safe, accessible, secure, and sustainable products, services, and supply chains.  

Please join our speakers, Monique K. Mansoura, executive director for global health security and biotechnology at The MITRE Corporation, and Victor Suarez, Colonel (ret.), U.S. Army, senior fellow (visiting) at The Council on Strategic Risks and founder of BluZoneBio, to explore challenges facing the U.S. pharma and biotech industries and approaches to strengthening the national security resilience of those industries in a world marked by health and geopolitical threats.

Top Stories on CFR

Venezuela

The opposition and the Maduro regime will face a new variable at the negotiating table: the United States and its heavy military presence off Venezuela’s coast. As a direct party, the Trump administration now has an opportunity to learn the lessons of the past to bring a potential conflict to a close. 

Taiwan

Assumptions about how a potential conflict between the United States and China over Taiwan would unfold should urgently be revisited. Such a war, far from being insulated, would likely draw in additional powers, expand geographically, and escalate vertically.

United States

Three CFR experts discuss President Donald Trump’s decision to allow Nvidia to sell advanced AI chip sales to China and what implications it could have for the future of AI, U.S. national security policy, and Chinese relations.